Insulin glargine injection) recalled over labeling errors
- Recall date
- January 19, 2022
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Official notice title
- Mylan Pharmaceutical Inc. recalls Semglee — Insulin glargine injection), 100 units/ml (U-100), 3mL prefilled pens
- Brand / firm
- Mylan Pharmaceutical Inc., Semglee
Why it was recalled
Missing Label — Mislabeling
What was recalled
Insulin glargine injection), 100 units/ml (U-100), 3mL prefilled pens
Read the official recall notice →
Get recall alerts
Free email alert whenever Mylan Pharmaceutical Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Mylan Pharmaceutical Inc., Semglee